References
- Feinstone S M, Kapikian A Z, Purcell R H, Alter H J, Holland P V. Transfusion‐associated hepatitis not due to viral hepatitis type A or B. N Engl J Med 1975; 292: 767–770
- Alter M J, Coleman P J, Alexander W J, Kramer E, Miller J K, Mandel E, Hadler S C, Margolis H S. Importance of heterosexual activity in the transmission of hepatitis B and non‐A, non B hepatitis. JAMA 1989; 262: 1201–1205
- Choo Q ‐L, Kuo G, Weiner A J, Overby L R, Bradley D W, Houghton M. Isolation of a cDNA clone derived from blood‐borne non‐A, non‐B viral hepatitis genome. Science 1989; 244: 359–362
- Kuo G, Choo Q ‐L, Alter H J, Gitnick G L, Redeker A G, Purcell R H, Miyamura T, Dienstag J L, Alter M J, Stevens C E, Tegtmeier G E, Bonino F, Colombo M, Lee W ‐S, Kuo C, Berger K, Shuster J R, Overby L R, Bradley D W, Houghton M. An assay for circulating antibodies to a major etiologic virus of human non‐A, non‐B hepatitis. Science 1989; 244: 362–364
- Widell A, Sundström G, Hansson B G, Fex G, Moestrup T, Nordenfelt E. Relation between donor transaminase and recipient hepatitis non‐A., non‐B in Sweden. Vox Sang 1988; 54: 154–159
- Aach R D, Szmuness W, Mosley J W, Hollinger F B, Kahn R A, Stevens C E, Edwards V M, Werch J. Serum alanine aminotransferase of donors in relation to the risk of non‐A, non‐B hepatitis in recipients. N Engl J Med 1981; 304: 989–994
- Weiland O, Berg J VR, Flehmig B, Lindh G, Lundbergh P. Acute viral hepatitis, types A, B, and non‐A, non‐B: A prospective study of the epidemiological, laboratory and prognostic aspects in 280 consecutive cases. Scand J Infect Dis 1981; 13: 247–255
- Widell A, Hansson B G, Moestrup T, Serléus Z, Mathiesen L R, Johnsson T. Acute hepatitis A, B and non‐A, non‐B in a Swedish community studied over a ten‐year period. Scand J Infect Dis 1982; 14: 253–259
- Rakela J, Redeker A G. Chronic liver disease after acute non‐A, non‐B viral hepatitis. Gastroenterology 1979; 77: 1200–1202
- Aledort L M, Levine P H, Hilgartner M, Blatt P, Spero J A, Goldberg J D, Bianchi L, Desmet V, Scheuer P, Popper H, Berk P D. A study of liver biopsies and liver disease among hemophiliacs. Blood 1985; 66: 367–372
- Esteban J I, Esteban R, Viladomiu L, López‐Talavera J C, González A, Hernández J M, Roget M, Vargas V, Genescà J, Buti M, Guardia J, Houghton M, Choo Q ‐L, Kuo G. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 2: 294–297
- Roggendorf M, Deinhardt F, Rasshofer R, Eberle J, Hopf U, Möller B, Zachoval R, Pape G, Schramm W, Rommel F. Antibodies to hepatitis C virus. Lancet 1989; 2: 324–325
- Noel L, Guerois C, Maisonneuve P, Verroust F, Laurian Y. Antibodies to hepatitis C virus in hemophilia. Lancet 1989; 2: 560
- Ludlam C A, Chapman D, Cohen B, Litton P A. Antibodies to hepatitis C virus in hemophilia. Lancet 1989; 2: 560–561
- Schulman S, Grillner L. Antibodies against hepatitis C in a population of Swedish haemophiliacs and heterosexual partners. Scand J Infect Dis 1990; 22: 393–397
- Mannucci P M, Colombo M. Virucidal treatment of clotting factor concentrates. Lancet 1988; 2: 782–785